Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $19,652 - $21,896
-195 Reduced 7.7%
2,338 $254,000
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $23,343 - $27,476
241 Added 10.51%
2,533 $256,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $12,262 - $14,386
129 Added 5.96%
2,292 $251,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $209,291 - $242,320
2,163 New
2,163 $209,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $276,950 - $306,388
-2,374 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $251,145 - $295,634
2,374 New
2,374 $275,000
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $394,000 - $464,192
-3,620 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $180,915 - $197,145
1,723 Added 90.83%
3,620 $396,000
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $173,841 - $211,117
1,897 New
1,897 $206,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Laidlaw Wealth Management LLC Portfolio

Follow Laidlaw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laidlaw Wealth Management LLC with notifications on news.